| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/15/2004 | US20040009557 Comprises nucleotide sequences coding non-gum arabic fusion protein for use in food processing and cosmetics |
| 01/15/2004 | US20040009555 Comprises nucleotide sequences coding gum arabic for use in food processing and cosmetics |
| 01/15/2004 | US20040009554 QM-7 and QT-6 cells transfected with mutant cell surface expressed channel receptors and assays using the transfected cells |
| 01/15/2004 | US20040009553 Comprises nucleotide sequences coding cardiolipin for diagnosis and treatment of lung, heart and respiratory disorders |
| 01/15/2004 | US20040009552 Comprises tumor necrosis factor protein for diagnosis and treatment of reperfusion injury, nervous system, liver and cardiovascular disorders |
| 01/15/2004 | US20040009551 Comprises nucleotide sequences coding peptide antibiotic for treatment of parasitic infection and cell proliferative disorders |
| 01/15/2004 | US20040009550 Export and modification of (poly)peptides in the lantibiotic way |
| 01/15/2004 | US20040009548 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 01/15/2004 | US20040009547 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
| 01/15/2004 | US20040009546 Compositions and methods for inhibiting microbial adhesion |
| 01/15/2004 | US20040009541 Novel carcinoma-related genes and polypeptides and methods of use thereof |
| 01/15/2004 | US20040009535 Comprises immunoglobulin which inhibits homodimer formation associated with a transforming growth factor polypeptide, sclerostin (SOST), for treating osteopenia, osteoporosis and bone fractures |
| 01/15/2004 | US20040009531 A quantitative analyzing the concentration of peptide with monoclonal antibody produced by the fused cell hybrid; medical diagnosis |
| 01/15/2004 | US20040009530 Engineered binding proteins |
| 01/15/2004 | US20040009528 A biochips comprising a solid support for binding immunoglobulin G protein through a linking maleimide group, by contacting the surface with maleic anhydride |
| 01/15/2004 | US20040009524 Transfecting cells with two vectors, measuring transcription activity of androgen receptor protein, a transcription factors, interaction between receptor protein and co-modulator; medical diagnosis |
| 01/15/2004 | US20040009513 pDJA1, a cardiac specific gene, corresponding proteins, and uses thereof |
| 01/15/2004 | US20040009511 Identification of compounds which stimulate bone formation using a cell-based screening assay targeting BMP signaling |
| 01/15/2004 | US20040009509 Isolated human proteins that show high homology to human disease proteins, nucleic acid molecules encoding these human proteins, and uses thereof |
| 01/15/2004 | US20040009508 RTVP based compositions and methods for the treatment of prostate cancer |
| 01/15/2004 | US20040009505 A pair of genetic engineered primers for the mutagenic amplification, therapeutic treatment |
| 01/15/2004 | US20040009502 Identification and tissue distribution of two novel spliced variants of the mouse LATS2 gene |
| 01/15/2004 | US20040009501 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor |
| 01/15/2004 | US20040009491 Diagnostic and therapeutic methods useful for diagnosing, treating, preventing and/or prognosing disorders related to plasma membrane associated polynucleotides, antigens, and antibodies |
| 01/15/2004 | US20040009490 Polynucleotides isolated from Lactobacillus rhamnosus, oligonucleotide probes and primers, genetic constructs comprising the polynucleotides, biological materials, including plants, organisms incorporating them |
| 01/15/2004 | US20040009488 Nucleic acids, proteins, and antibodies |
| 01/15/2004 | US20040009480 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 01/15/2004 | US20040009478 Human nucleic acid sequences from prostate tumor tissue |
| 01/15/2004 | US20040009476 Stress-regulated genes of plants, transgenic plants containing same, and methods of use |
| 01/15/2004 | US20040009474 Novel human polynucleotides and polypeptides encoded thereby |
| 01/15/2004 | US20040009469 Polypeptides and polynucleotides useful in methods of inducing immune response against flaviviruses, including dengue viruses |
| 01/15/2004 | US20040009468 Allelic variants of HERV-K18, method for analysis thereof and use in the determination of genetic predisposition for disorders involving the HERV-K18 provirus |
| 01/15/2004 | US20040009463 Method for PR-39 peptide mediated selective inhibition of IkappaBalpha |
| 01/15/2004 | US20040009193 Lipid bilayer membrane derived from a eukaryotic microorganism as an outer membrane |
| 01/15/2004 | US20040009192 Diagnosis of and vaccination against |
| 01/15/2004 | US20040009191 Inactivated virulence genes |
| 01/15/2004 | US20040009190 Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV) |
| 01/15/2004 | US20040009188 Present invention relates to a polypeptide antigen which derives from the gp41 protein, and also to the use thereof for immunization against HIV-related infection |
| 01/15/2004 | US20040009187 Rotavirus subunit vaccine |
| 01/15/2004 | US20040009186 Immunogenic peptides |
| 01/15/2004 | US20040009185 Enhancing the immune response to an antigen by presensitzing with an inducing agent prior to immunizing with the agent and the antigen |
| 01/15/2004 | US20040009184 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 01/15/2004 | US20040009183 Recombinant DNA construct comprising a vector and at least one nucleic acid fragment comprising any combination of proteins selected from the group consisting of mSEA and mSEB; food poisoning |
| 01/15/2004 | US20040009177 In particular, amino acid sequences in the respiratory syncytial vorus G glycoprotein, containing the chemokine motif defined as C-X-X-X-C (or CX3C), are identified that are essential in causing RSV infection and disease |
| 01/15/2004 | US20040009176 Treating inflammatory joint diseases by inhibiting cadherin-11 mediated cellular function |
| 01/15/2004 | US20040009171 Methods for the treatment of carcinoma |
| 01/15/2004 | US20040009167 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 01/15/2004 | US20040009165 Lysosomal enzymes and lysosomal enzyme activators |
| 01/15/2004 | US20040009164 PSP94 diagnostic reagents and assays |
| 01/15/2004 | US20040009163 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2004 | US20040009150 Administering polypeptides homologous to human interleukin sequences or fusion proteins as anticarcinogenic agents |
| 01/15/2004 | US20040009149 Multimeric binding complexes |
| 01/15/2004 | US20040009148 Compositions and methods for modifying toxic effects of proteinaceous compounds |
| 01/15/2004 | US20040009147 Administering mixtures of antibodies and tumor necrosis factors, immunosuppressants, antibiotics, antiinflammatory agents, cytokines, angiogenesis inhibitors or fibroblast growth factors; prophylaxis of graft versus host disease |
| 01/15/2004 | DE20121978U1 Novel chemically modified genomic DNA sequences, useful in the characterization, classification, differentiation, grading, staging, treatment and/or diagnosis of astrocytomas or predisposition to astrocytomas |
| 01/15/2004 | DE20121975U1 Oligonucleotide for diagnosing and treating tumors and cancer especially gliomas, astrocytomas and oligodendromas, comprises chemically modified genomic sequences of genes associated with tumors and cancers |
| 01/15/2004 | DE20121964U1 New nucleic acid, useful for diagnosis and therapy of metabolic disease, solid tumor and cancers, comprises segment of chemically modified genomic sequences of genes associated with metabolism |
| 01/15/2004 | DE20121960U1 New nucleic acid derived from chemically treated metastasis genes, useful for diagnosis of cancers by analysis of cytosine methylation, also for treatment |
| 01/15/2004 | DE10229729A1 Neue Nukleinsäuresequenzen und deren Verwendung in Verfahren zum Erreichen einer Pathogenresistenz in Pflanzen New nucleic acid sequences and to their use in methods for obtaining a pathogen resistance in plants |
| 01/15/2004 | CA2527619A1 Osteoinductive biomaterials |
| 01/15/2004 | CA2509684A1 Tumor antigens bfa4 and bcy1 for prevention and/or treatment of cancer |
| 01/15/2004 | CA2492074A1 Humanized renilla reniformis green fluorescent protein as a scaffold |
| 01/15/2004 | CA2491907A1 Oncolytic virus replicating selectively in tumor cells |
| 01/15/2004 | CA2491690A1 Plastid genetic engineering via somatic embryogenesis |
| 01/15/2004 | CA2491639A1 Expression of the human igf-1 in transgenic plastids |
| 01/15/2004 | CA2491637A1 Methods for identifying modulators of mda-7 mediated apoptosis |
| 01/15/2004 | CA2491607A1 Plant peptide with antimicrobial activity |
| 01/15/2004 | CA2491513A1 Compositions and methods for ligament growth and repair |
| 01/15/2004 | CA2491508A1 Hcv fusion proteins with modified ns3 domains |
| 01/15/2004 | CA2491488A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/15/2004 | CA2491417A1 Method for screening an agent for improving insulin resistance |
| 01/15/2004 | CA2491411A1 The rice restorer gene to the rice bt type cytoplasmic male sterility |
| 01/15/2004 | CA2491406A1 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 01/15/2004 | CA2491321A1 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 01/15/2004 | CA2491286A1 Methods of screening compounds for grk6 modulating activity |
| 01/15/2004 | CA2491178A1 Full-length interferon gamma polypeptide variants |
| 01/15/2004 | CA2491064A1 Method of producing plants having enhanced transpiration efficiency and plants produced therefrom |
| 01/15/2004 | CA2491056A1 Benzoate- and anthranilate-inducible promoters |
| 01/15/2004 | CA2491011A1 Cationic linear peptides having antibacterial and/or antifungal properties |
| 01/15/2004 | CA2490572A1 Pig binding protein from adipocytes |
| 01/15/2004 | CA2489754A1 .beta.-sheet breaking peptides |
| 01/15/2004 | CA2489588A1 Compositions and methods for the treatment of immune related diseases |
| 01/15/2004 | CA2489562A1 Mitotic kinesin binding site |
| 01/15/2004 | CA2488725A1 Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism |
| 01/14/2004 | EP1380650A1 Conditionally replicating viral vectors and their use |
| 01/14/2004 | EP1380645A2 Production in bacteria ad yeast of hemoglobin and analogues thereof |
| 01/14/2004 | EP1380594A1 Fibroblast growth factor-10 |
| 01/14/2004 | EP1380593A1 Soluble rage protein |
| 01/14/2004 | EP1380592A1 Cell surface layer-binding protein and utilization thereof |
| 01/14/2004 | EP1379882A1 Diagnostic and therapeutic use of a nuclear restricted protein for alzheimer's disease and related neurodegenerative disorders |
| 01/14/2004 | EP1379880A2 Screening for drugs against disorders associated with schizophrenia |
| 01/14/2004 | EP1379879A2 Diagnosis and treatment of alzheimer's disease |
| 01/14/2004 | EP1379878A2 Affinity selection-based screening of hydrophobic proteins |
| 01/14/2004 | EP1379874A1 Phycoerythrin labeled thyronine analogues and assays using the labeled analogues |
| 01/14/2004 | EP1379701A2 Elimination of endogenous porcine retrovirus |
| 01/14/2004 | EP1379695A2 New polynucleotides and polypeptides of the ifnalpha-21 gene |
| 01/14/2004 | EP1379691A1 Differentially methylated sequences in pancreatic cancer |
| 01/14/2004 | EP1379688A2 Polymorphisms in the human cmoat gene and uses thereof |
| 01/14/2004 | EP1379678A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 01/14/2004 | EP1379677A2 Production of high levels of trangenic factor ix without gene rescue, and its therapeutic uses |